Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Electrocardiogram qrs complex prolonged? 83 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Electrocardiogram qrs complex prolonged have been filed in association with LORAZEPAM (Lorazepam). This represents 0.3% of all adverse event reports for LORAZEPAM.

83
Reports of Electrocardiogram qrs complex prolonged with LORAZEPAM
0.3%
of all LORAZEPAM reports
36
Deaths
66
Hospitalizations

How Dangerous Is Electrocardiogram qrs complex prolonged From LORAZEPAM?

Of the 83 reports, 36 (43.4%) resulted in death, 66 (79.5%) required hospitalization, and 46 (55.4%) were considered life-threatening.

Is Electrocardiogram qrs complex prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Electrocardiogram qrs complex prolonged?

BUPROPION (604) FLECAINIDE (324) AMITRIPTYLINE (289) LAMOTRIGINE (256) QUETIAPINE (217) LOPERAMIDE (209) VENLAFAXINE (175) ESCITALOPRAM OXALATE (148) AMLODIPINE (145) PROPRANOLOL (133)

Which LORAZEPAM Alternatives Have Lower Electrocardiogram qrs complex prolonged Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Electrocardiogram qrs complex prolonged Reports All Drugs Causing Electrocardiogram qrs complex prolonged LORAZEPAM Demographics